Nan Fung Group Holdings LTD Bei Gene, Ltd. Transaction History
Nan Fung Group Holdings LTD
- $103 Million
- Q3 2024
A detailed history of Nan Fung Group Holdings LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 23,022 shares of BGNE stock, worth $4.39 Million. This represents 5.03% of its overall portfolio holdings.
Number of Shares
23,022
Previous 23,022
-0.0%
Holding current value
$4.39 Million
Previous $3.28 Million
57.37%
% of portfolio
5.03%
Previous 3.82%
Shares
3 transactions
Others Institutions Holding BGNE
# of Institutions
250Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.01 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.23 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$986 Million26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$948 Million0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$706 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $19.8B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...